CELEX: 62019TA0678
Language: en
Date: 2021-06-16 00:00:00
Title: Case T-678/19: Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel) (EU trade mark — Invalidity proceedings — International registration designating the European Union — Figurative mark Enterosgel — No bad faith — Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))

2.8.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 310/22
            
         
      Judgment of the General Court of 16 June 2021 — Health Product Group v EUIPO — Bioline Pharmaceutical (Enterosgel)
      (Case T-678/19) (1)
      
      (EU trade mark - Invalidity proceedings - International registration designating the European Union - Figurative mark Enterosgel - No bad faith - Article 51(1)(b) of Regulation (EC) No 40/94 (now Article 59(1)(b) of Regulation (EU) 2017/1001))
      (2021/C 310/26)
      Language of the case: English
      
         Parties
      
      
         Applicant: Health Product Group sp. z o.o. (Warsaw, Poland) (represented by: M. Kondrat, M. Stępień and A. Przytuła, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: E. Markakis and V. Ruzek, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Bioline Pharmaceutical AG (Baar, Switzerland) (represented by: T. Grucelski, H. Gajek and M. Furmańska, lawyers)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 8 August 2019 (Case R 482/2018-4), relating to invalidity proceedings between Health Product Group and Bioline Pharmaceutical.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Health Product Group sp. z o.o. to pay the costs.
               
            
         (1)  OJ C 399, 25.11.2019.